(Q73063987)
Statements
Administration of a CD31-derived peptide delays the onset and significantly increases survival from lethal graft-versus-host disease (English)
Chen Y
Schlegel PG
Tran N
Thompson D
1 February 1997
scientific article published on 01 February 1997